These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 35127875)

  • 1. Different Rates of Bioprosthetic Aortic Valve Failure With Perimount™ and Trifecta™ Bioprostheses.
    Lange R; Alalawi Z; Voss S; Boehm J; Krane M; Vitanova K
    Front Cardiovasc Med; 2021; 8():822893. PubMed ID: 35127875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Externally mounted versus internally mounted leaflet aortic bovine pericardial bioprosthesis: meta-analysis.
    Yokoyama Y; Sakurai Y; Kuno T; Takagi H; Fukuhara S
    Gen Thorac Cardiovasc Surg; 2023 Apr; 71(4):207-215. PubMed ID: 36598643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Leaflet Mechanical Properties of Carpentier-Edwards Perimount Magna Pericardial Aortic Bioprostheses.
    Kuang H; Xuan Y; Lu M; Mookhoek A; Wisneski AD; Guccione JM; Ge L; Tseng EE
    J Heart Valve Dis; 2017 Jan; 26(1):81-89. PubMed ID: 28544835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mid-Term Clinical Outcomes and Hemodynamic Performances of Trifecta and Perimount Bioprostheses following Aortic Valve Replacement.
    Toto F; Leo L; Klersy C; Torre T; Theologou T; Pozzoli A; Caporali E; Demertzis S; Ferrari E
    J Cardiovasc Dev Dis; 2023 Mar; 10(4):. PubMed ID: 37103018
    [No Abstract]   [Full Text] [Related]  

  • 5. Comparison of four aortic bioprostheses: Hancock II
    Bajorek N; Filip G; Malinowski K; Kędziora A; Mazur P; Ramaprabhu K; Bartuś K; Batko J; Rams DJ; Deja M; Widenka K; Tobota Z; Maruszewski BJ; Burysz M; Litwinowicz R
    J Thorac Dis; 2024 Aug; 16(8):5018-5030. PubMed ID: 39268099
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trifecta versus perimount bioprosthesis for surgical aortic valve replacement; systematic review and meta-analysis.
    Yokoyama Y; Kuno T; Takagi H; Fukuhara S
    J Card Surg; 2021 Nov; 36(11):4335-4342. PubMed ID: 34499386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trifecta Versus Perimount Magna Ease Aortic Valve Prostheses.
    Biancari F; Valtola A; Juvonen T; Husso A; Dahlbacka S; Laakso T; Jalava MP; Tauriainen T; Ahvenvaara T; Kinnunen EM; Niemelä M; Mäkikallio T; Eskola M; Virtanen MPO; Maaranen P; Rosato S; Anttila V; Vento A; Airaksinen J; Raivio P
    Ann Thorac Surg; 2020 Sep; 110(3):879-888. PubMed ID: 32061588
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Premature Structural Failure of Trifecta Bioprosthesis in Midterm Follow-up: A Single-Center Study.
    Kattach H; Shah BN; Harden S; Barlow CW; Miskolczi S; Velissaris T; Ohri SK
    Ann Thorac Surg; 2021 Nov; 112(5):1424-1431. PubMed ID: 33338482
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mid-term outcomes of Sapien 3 versus Perimount Magna Ease for treatment of severe aortic stenosis.
    Virtanen MPO; Eskola M; Savontaus M; Juvonen T; Niemelä M; Laakso T; Husso A; Jalava MP; Tauriainen T; Ahvenvaara T; Maaranen P; Kinnunen EM; Dahlbacka S; Laine M; Mäkikallio T; Valtola A; Raivio P; Rosato S; D'Errigo P; Vento A; Airaksinen J; Biancari F
    J Cardiothorac Surg; 2020 Jun; 15(1):157. PubMed ID: 32600369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. An in vitro comparison of internally versus externally mounted leaflets in surgical aortic bioprostheses.
    Vriesendorp MD; de Lind van Wijngaarden RAF; Rao V; Moront MG; Patel HJ; Sarnowski E; Vatanpour S; Klautz RJM
    Interact Cardiovasc Thorac Surg; 2020 Mar; 30(3):417-423. PubMed ID: 31778161
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Original Article--Mid-term Clinical and Hemodynamic Outcomes in Middle Age Patients Post Trifecta™ (Abbott) Aortic Valve Replacement: A Single-center Study.
    Khaliel FH; Al Aboud MS; Althibait SA; Yezli S; Al Muaythir EA; Alamro B; Galzerano D
    J Saudi Heart Assoc; 2024; 36(1):1-7. PubMed ID: 38566901
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment of failed aortic bioprostheses: An evaluation of conventional redo surgery and transfemoral transcatheter aortic valve-in-valve implantation.
    Woitek FJ; Stachel G; Kiefer P; Haussig S; Leontyev S; Schlotter F; Mende M; Hommel J; Crusius L; Spindler A; Mohr FW; Schuler G; Thiele H; Borger MA; Linke A; Holzhey D; Mangner N
    Int J Cardiol; 2020 Feb; 300():80-86. PubMed ID: 31740140
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro coronary flow after transcatheter aortic valve-in-valve implantation: A comparison of 2 valves.
    Stock S; Scharfschwerdt M; Meyer-Saraei R; Richardt D; Charitos EI; Sievers HH; Hanke T
    J Thorac Cardiovasc Surg; 2017 Feb; 153(2):255-263.e1. PubMed ID: 28104190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Structural Deterioration of Transcatheter Versus Surgical Aortic Valve Bioprostheses in the PARTNER-2 Trial.
    Pibarot P; Ternacle J; Jaber WA; Salaun E; Dahou A; Asch FM; Weissman NJ; Rodriguez L; Xu K; Annabi MS; Guzzetti E; Beaudoin J; Bernier M; Leipsic J; Blanke P; Clavel MA; Rogers E; Alu MC; Douglas PS; Makkar R; Miller DC; Kapadia SR; Mack MJ; Webb JG; Kodali SK; Smith CR; Herrmann HC; Thourani VH; Leon MB; Hahn RT;
    J Am Coll Cardiol; 2020 Oct; 76(16):1830-1843. PubMed ID: 33059828
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term survival after Carpentier-Edwards Perimount aortic valve replacement in Western Denmark: a multi-centre observational study.
    Krasniqi L; Kronby MP; Riber LPS
    J Cardiothorac Surg; 2021 May; 16(1):130. PubMed ID: 33990211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Durability and Performance of 2298 Trifecta Aortic Valve Prostheses: A Propensity-Matched Analysis.
    Yongue C; Lopez DC; Soltesz EG; Roselli EE; Bakaeen FG; Gillinov AM; Pettersson GB; Semple ME; Rajeswaran J; Tong MZ; Jaber W; Blackstone EH; Svensson LG; Johnston DR
    Ann Thorac Surg; 2021 Apr; 111(4):1198-1205. PubMed ID: 33011168
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Six-year follow-up of aortic valve reoperation rates: Carpentier-Edwards Perimount versus St. Jude Medical Trifecta.
    Stubeda H; Aliter H; Gainer RA; Theriault C; Doucette S; Hirsch GM
    J Card Surg; 2020 Dec; 35(12):3347-3353. PubMed ID: 32985014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Durability after aortic valve replacement with the Mitroflow versus the Perimount pericardial bioprosthesis: a single-centre experience in 2393 patients.
    Nielsen PH; Hjortdal V; Modrau IS; Jensen H; Kimose HH; Terp K; Poulsen SH; Smerup M; Nielsen SL
    Eur J Cardiothorac Surg; 2016 Jun; 49(6):1705-10. PubMed ID: 26984983
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aortic Valve Replacement With Mechanical Valves vs Perimount Bioprostheses in 50- to 69-Year-Old Patients.
    Lu R; Dismorr M; Glaser N; Sartipy U
    JACC Adv; 2023 Jun; 2(4):100359. PubMed ID: 38938255
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Leaflet stress quantification of porcine vs bovine surgical bioprostheses: an
    Stanová V; Godio Raboutet Y; Barragan P; Thollon L; Pibarot P; Rieu R
    Comput Methods Biomech Biomed Engin; 2022 Jan; 25(1):40-51. PubMed ID: 34219548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.